KU Leuven (RA Clinical Research Group, Skeletal Biology and Engineering Research Centre, Department of Development and Regeneration, KU Leuven)
What is the optimal tapering strategy for rituximab in patients with Rheumatoid Arthritis: comparison of interval prolongation with disease activity guided dose reduction
Rituximab is an effective drug, but it is expensive and might be accompanied by an increased infection risk. Therefore, lowering the dose might be beneficial. According to the cu…
Lesen Sie hier mehr darüber
